Health:Further

Vic and Marcus recap the Jumpstart Health Summit, including a workshop where non-technical founders built full AI-driven products and an agentic investment bank in under 48 hours, followed by key discussions from the summit on healthcare transformation, AI infrastructure, venture capital evolution, and leadership changes at Jumpstart Health. They break down major economic signals including declining job openings, stock market performance, and rising risks in private credit markets, then analyze healthcare policy shifts targeting hospital pricing practices and UnitedHealthcare’s push into AI-driven member tools. The episode also covers major pharma momentum led by Eli Lilly across acquisitions, GLP-1 advancements, and AI-powered drug discovery, alongside emerging trends in crypto-backed mortgages, agentic commerce, and Coinbase’s expanding role in financial infrastructure. They close with a deep dive into AI disruption, highlighting a two-person billion-dollar company, open-source model acceleration, security risks, and breakthroughs that could reshape hardware demand and the future of work.

Links
Story 1 Jobs and Equity market
11:37 - U.S. Job Openings and Hiring Fell in February WSJ
18:10 - Here’s What Worked During a Rough Quarter for Markets WSJ
Story 2 Private credit watch
19:17 - What Banks Stand to Lose From the Private-Credit Mess WSJ
Story 3 VC rundown
23:14 - WHOOP Secures $575M, Reaches $10B Valuation MedCity
Story 4  DOJ v NY Pres
25:21 - Justice Department Files Antitrust Lawsuit Against NewYork-Presbyterian WSJ
Story 6 UHG launches AI Companion
30:12 - UnitedHealthcare launches Avery, a generative AI companion for members Fierce Healthcare
Story 7 1st Reimbursement for Robot Companion
32:22 - Intuition Robotics secures Medicaid coverage for social AI robot ElliQ in Washington State Fierce Healthcare
Story 8 Eli Lilly moves
37:21 - Eli Lilly to Buy Centessa Pharmaceuticals for Initial $6.3 Billion WSJ
37:55 - Eli Lilly Gets Speedy FDA Nod for Oral GLP-1 Drug, a Competitor to New Novo Nordisk Pill MedCity
38:52 - Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market CNBC
Story 9 Web3 rundown
39:54 - Fannie Mae to Accept Crypto-Backed Mortgages for the First Time WSJ
41:54 - Coinbase’s AI payments system joins Linux Foundation, gathers support from Google, Stripe, AWS and others Coindesk
45:57 - Coinbase clears key regulatory hurdle in bid to bolster its stablecoin business CNBC 
Story 10 1st $B - 2 person AI startup is healthcare
47:24 - How A.I. Helped One Man (and His Brother) Build a $1.8 Billion Company NYT
Story 11 Antropic
50:27 - Anthropic Races to Contain Leak of Code Behind Claude AI Agent WSJ
51:19 - Claw Code Launches Open-Source AI Coding Agent Framework With 72,000 GitHub Stars in First Days 24-7
Story 12 Google
54:00 - Google announces Gemma 4 open AI models, switches to Apache 2.0 license ArsTechnica
56:30 - Google now lets you direct avatars through prompts in its Vids app TechCrunch
57:00 - Google’s TurboQuant Breakthrough Just Rewrote the AI Playbook Yahoo 

What is Health:Further?

Every week, healthcare VCs and Jumpstart Health Investors co-founders Vic Gatto and Marcus Whitney review and unpack the happenings in US Healthcare, finance, technology and policy. With a firm belief that our healthcare system is doomed without entrepreneurship, they work through the mud to find the jewels, highlight headwinds and tailwinds, and bring on the smartest guests to fill in the gaps.